Vrati se na vrh


D E C I S I O N The concentration which shall be acquired in the market of production and sale of specialized (generic) pharmaceutical products in Bosnia and Herzegovina as result of takeover of Hemofarma a.d. Vršac, Republic of Serbia – Hemofarm d.o.o. Banja Luka, Bosnia and Herzegovina by STADA Arzneimittel AG, Stadastrasse 2-18, Bad Vilbal, Federal Republic of Germany, by means


Извјештај о раду Конкуренцијског савјета БиХ за 2006. годину


Rješenje Skupština grada Banja Luka